Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

Autor: Jose Javier Pi Barrio, Carlos F. Lopez, Daniel Castellano, Vicente Alonso, Ángel Castaño‐Pascual, Ángel Segura, Paula Jiménez-Fonseca, Alex Teulé, Barbara Nuñez‐Valdovinos, Alberto Carmona-Bayonas, Ana Custodio, Jose Angel Diaz‐Perez, Mónica Marazuela, Isabel Sevilla, Marta Llanos, Adolfo Beguiristain, Teresa Alonso, Marta Benavent, Rocio Garcia-Carbonero, Maria Purificacion Martinez del Prado, Jaume Capdevila

Publikováno v: Oncologist
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

BackgroundGastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a complex family of tumors of widely variable clinical behavior. The World Health Organization (WHO) 2010 classification provided a valuable tool to stratify neuroendocrine neop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2b2c2739d290180791323c3cffaa376
https://hdl.handle.net/10668/12006

Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines.

Autor: Matsuhashi N; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Takahashi T; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Tomita H; Department of Tumor Pathology, Gifu University School of Medicine, Gifu 501-1194, Japan., Araki H; Department of Gastroenterology, Gifu University School of Medicine, Gifu 501-1194, Japan., Ibuka T; Department of Gastroenterology, Gifu University School of Medicine, Gifu 501-1194, Japan., Tanaka K; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Tanahashi T; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Matsui S; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Sasaki Y; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Tanaka Y; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Okumura N; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Yamaguchi K; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Osada S; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan., Yoshida K; Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501-1194, Japan.

Publikováno v: Molecular and clinical oncology [Mol Clin Oncol] 2017 Sep; Vol. 7 (3), pp. 476-480. Date of Electronic Publication: 2017 Jul 18.